SRSF2 and acute myeloid leukemia: To quantify the deviation of nuclei in MOLM14, OCI-AML2, and SRSF2 Mut/WT primary AML cells (WT and mutant, untreated and treated with RKI-1447), we further calculated the nucleus sphericity.